Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Seattle › NPI 1619580891
Lab

Altius Institute for Biomedical Sciences

Altius Institute for Biomedical Sciences was paid $2.08M by Medicaid between Sep 2020 and Feb 2023, across 2 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 100% of everything it billed.

33Billing provider infoALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
SEATTLE, WA 98121
33aNPI1619580891assigned 08/26/2020
28Total paid$2.08M
24GClaims70,748
24DCodes billed2
24AFirst – last monthSep 2020 – Feb 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Washington

Rank by total paid#18 of 76
Median peer was paid$90K
This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration100% of spending on code U0003 with only 2 total codes billed. Highly concentrated billing profile.
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20204,412$249K
202141,384$1.11M
202224,562$713K
2023390$10K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 100% 44,679 31,190 $2.08M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 26,069 20,935 $940.81

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSMITH-JENNESS, LISA (CONTROLLER)